A novel sunscreen concept that uses lignin-derived aromatics irreversibly absorbed onto silica gel particles to block UV light. The silica carrier prevents skin absorption of chemicals and eliminates reef-damaging runoff, offering a safer alternative to conventional chemical sunscreens facing regulatory bans.
This solution addresses two major concerns with conventional chemical sunscreens: human health risks from chemicals passing through the skin into the bloodstream, and environmental damage to coral reefs from sunscreen chemicals washing off into ocean water. The approach uses aromatic compounds derived from lignin, a natural polymer found in plants, absorbed irreversibly onto small silica gel particles. The lignin-derived aromatics chemically resemble existing sunblock molecules and provide UV-blocking capability, while the silica particles serve a dual purpose: scattering light to enhance protection and preventing the active compounds from passing through skin or entering waterways when the product washes off.
This concept offers a path to effective, natural-origin sun protection that avoids the health and environmental issues driving regulatory action against chemical sunscreens in certain regions.
Core approach:
Key advantages:
Validation methods:
Multiple lignin model structures have been synthesized to date, and the individual components of the concept (UV absorption by lignin aromatics, irreversible silica absorption, and silica light scattering) are well-established. The integrated formulation requires further development and validation. Under a sponsored research agreement, the team can provide data and physical samples for sponsor evaluation, with a research associate completing the work in approximately six months to twelve months depending on development scope. A startup has been formed around this concept, offering partners the option to engage through the company or directly with the university laboratory.
UC Davis is a comprehensive public research university in Northern California, combining a land-grant heritage with an integrated academic health system and a veterinary teaching hospital. Industry engages through co-located clinical and translational facilities in Sacramento, a campus-adjacent research park, pilot-scale food and bioprocessing facilities, and a statewide extension network for field-to-market deployment. Proximity to the Bay Area and California's Central Valley enables rapid collaboration with startups and established enterprises, while corporate relations staff streamline access to faculty, talent, and core labs. Research is supported by competitive federal funding from agencies such as NIH, NSF, USDA, and DOE. A dedicated technology transfer office and venture support programs provide IP management, licensing, and startup formation pathways for industry partnerships.